About · Lianhe Life CDMO & CRO

WHO WE ARE

A 700-person team that shares your timeline

Lianhe Life is a fully integrated contract development, manufacturing and research organisation headquartered in Shanghai, with operations in Suzhou, Hangzhou and Shenzhen.

Our scientists, engineers and QA specialists work across chemistry, biology, DMPK, toxicology, formulation and GMP manufacturing — connected by one quality system and one project management framework.

We have supported 62 IND filings, manufactured 9 commercial products and passed 180+ customer and regulatory audits, including FDA, EMA, PMDA and NMPA inspections.

MISSION & VALUES

Why partners stay with us

We think like your extended R&D and manufacturing team — because we are.

Mission

Accelerate every therapeutic to patients

We exist to move your program through every stage faster, at the quality regulators expect.

Vision

The most trusted integrated CDMO/CRO in Asia

A single partner from discovery to commercial launch — predictable, transparent, audit-ready.

Values

Quality · Integrity · Partnership

We disclose issues early. We protect your IP. We share credit for success.

OUR JOURNEY

Milestones

Twenty years of steady growth alongside our biotech and pharma partners.

2005

Founded in Shanghai

Started as a small medicinal chemistry CRO serving two Nasdaq biotech partners.

2009

Biology & DMPK added

Expanded into integrated discovery biology, DMPK and in vivo pharmacology services.

2013

First GMP API facility

Commissioned our first cGMP small-molecule API plant in Suzhou — 100 kg campaign capacity.

2017

Biologics CDMO launched

Opened our biologics CDMO in Hangzhou — 200 L single-use upstream and purification.

2019

First FDA inspection passed

Our Suzhou API site cleared an FDA pre-approval inspection — opened US commercial supply.

2022

Cell & gene therapy platform

Launched a dedicated ATMP facility with viral vector and CAR-T manufacturing capability.

2024

62 INDs supported

Crossed 62 IND filings supported, including 28 FDA and 14 EMA submissions.

2026

700+ team · 4 sites

Four integrated sites across Shanghai, Suzhou, Hangzhou and Shenzhen.

OUR TEAM

Scientists, engineers and QA specialists

A seasoned team with decades of pharma, biotech and regulatory experience.

Dr. Lin Wei

Founder / CEO

25 years in pharma R&D; former medicinal chemistry director at a top-20 multinational.

Dr. Susan Zhao

Chief Scientific Officer

Former discovery biology head; 60+ publications in oncology and immunology.

Dr. James Chen

Chief Manufacturing Officer

Former site head at a US commercial API facility; six FDA PAIs passed.

Dr. Maya Wong

Chief Quality Officer

20+ years in global pharma QA/QC; led multiple MHRA, PMDA and FDA inspections.

A CDMO and CRO you can partner with long-term